{"meta":{"query_hash":"d516a11c29d4","filters":{"venue":"Melanoma Management"},"cohort_total":7,"direct_labels_cover":0,"predictions_cover":7,"exported":7,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d516a11c29d4","api":"https://metacan.xera.ac/api/v1/cohort?venue=Melanoma+Management"},"results":[{"id":"W2035739780","doi":"10.2217/mmt.14.23","title":"Molecular pathology of cutaneous melanoma","year":2014,"lang":"en","type":"review","venue":"Melanoma Management","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Melanoma; Medicine; Pathology; Molecular pathology; Dermatology; Cancer research; Chemistry","score_opus":0.018627333910495203,"score_gpt":0.2881619542454667,"score_spread":0.2695346203349715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035739780","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042573467,0.9961966,0.00033368546,0.00023880241,0.00013987433,0.0000061755595,0.000023119832,0.000012129433,0.0026238335],"genre_scores_gemma":[0.0051148282,0.9925922,0.0003820677,0.0001847476,0.00018399907,0.000006095231,0.00005964382,0.0000025443285,0.0014738474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985933,0.000024388553,0.000017966568,0.000030010508,0.00005140251,0.000016901531],"domain_scores_gemma":[0.9998271,0.00006383234,0.00003604134,0.000009768815,0.00004823177,0.000015040437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025259124,0.0005768979,0.00070458953,0.00232144,0.00024267183,0.000832087,0.00043928123,0.0006925968,0.0025939962],"category_scores_gemma":[0.0004456392,0.00018047229,0.00035471725,0.001198879,0.0004897586,0.00083257235,0.0004914288,0.0010176314,0.0016338956],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004511273,0.00003958171,0.0010192002,0.009441397,0.000076258715,0.0011658301,0.00008764576,0.0003402337,0.007658881,0.004376127,0.024190463,0.9515593],"study_design_scores_gemma":[0.000008597096,0.000056313344,0.0040704277,0.003565685,0.00010318606,0.021651966,0.00012873225,0.00013902494,0.0024013764,0.0035927277,0.9642577,0.000024231595],"about_ca_topic_score_codex":0.00080383004,"about_ca_topic_score_gemma":0.0010777155,"teacher_disagreement_score":0.0025939962,"about_ca_system_score_codex":0.00043631007,"about_ca_system_score_gemma":0.000499898,"threshold_uncertainty_score":0.008677781},"labels":[],"label_agreement":null},{"id":"W2220471922","doi":"10.2217/mmt.15.13","title":"Oncolytics Biotech <sup>®</sup> Inc.: REOLYSIN <sup>®</sup> for Melanoma Therapy","year":2015,"lang":"en","type":"editorial","venue":"Melanoma Management","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Medicine; Cancer therapy; Melanoma; Cancer; Virology; Cancer research; Immunology; Internal medicine","score_opus":0.021502933453903177,"score_gpt":0.3040468738097407,"score_spread":0.2825439403558375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2220471922","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012543701,0.020754388,0.00041073712,0.025301054,0.9414865,0.00004729501,0.00009621048,0.00017319257,0.011605168],"genre_scores_gemma":[0.0013702434,0.022691784,0.00034430507,0.021977527,0.85934556,0.000037488353,0.00012232037,0.0001073896,0.09400349],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856,0.00013178764,0.00014438898,0.0001664137,0.00091043767,0.00008702818],"domain_scores_gemma":[0.9965011,0.0010472882,0.00030873765,0.00011592046,0.0013415173,0.0006853925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028655094,0.0022872319,0.0010958988,0.0017437057,0.001229735,0.0037947856,0.0013481189,0.006182331,0.0206296],"category_scores_gemma":[0.0051533733,0.00060686993,0.0011925396,0.0005858305,0.0010930367,0.0029577455,0.0007528741,0.008369611,0.020502837],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029862307,0.000017704006,0.000015811229,0.00019523936,0.0000062894587,0.00009084766,0.000010028238,0.000029729408,0.00028248958,0.000530492,0.98548603,0.013305512],"study_design_scores_gemma":[0.000022481763,0.000021264246,0.00009071719,0.00011028879,0.000008338721,0.00017329183,0.0000099309045,0.000059312108,0.00022005661,0.00046755295,0.998811,0.0000058233313],"about_ca_topic_score_codex":0.0005549481,"about_ca_topic_score_gemma":0.0012862049,"teacher_disagreement_score":0.0206296,"about_ca_system_score_codex":0.0016027136,"about_ca_system_score_gemma":0.001339408,"threshold_uncertainty_score":0.06901294},"labels":[],"label_agreement":null},{"id":"W2809197883","doi":"10.2217/mmt-2017-0026","title":"Combination Therapy for Metastatic Melanoma: A Pharmacist’s Role, Drug Interactions &amp; Complementary Alternative Therapies","year":2018,"lang":"en","type":"review","venue":"Melanoma Management","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Pharmacist; Vemurafenib; Metastatic melanoma; Drug; Intensive care medicine; Dabrafenib; Oncology; Trametinib; Melanoma; Internal medicine; Pharmacology; Cancer; Pharmacy; Cancer research; Nursing","score_opus":0.08007154233816013,"score_gpt":0.3657265639335599,"score_spread":0.2856550215953998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809197883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007361237,0.9962843,0.00010878716,0.001298289,0.00046324267,0.0000047277704,0.000013480101,0.0000060824977,0.0017474187],"genre_scores_gemma":[0.0008761922,0.9961817,0.00024247864,0.0009025252,0.0005602247,0.0000070293518,0.000020942323,0.0000017791164,0.0012071589],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997671,0.000058982256,0.000030283529,0.000030393301,0.00009558958,0.000017641954],"domain_scores_gemma":[0.9995541,0.00025020624,0.000054629665,0.0000102795775,0.000095106974,0.000035688558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005094546,0.00057649444,0.0008692971,0.0014855172,0.00029754173,0.0008770194,0.00064728566,0.0012435497,0.0046805562],"category_scores_gemma":[0.00086556026,0.00017260597,0.0005010241,0.0012463032,0.00043729082,0.0014711622,0.0005403313,0.0025465786,0.0016423428],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041051353,0.0000556161,0.00013314713,0.009565092,0.00007158179,0.00026756618,0.000053862677,0.00016982776,0.00050010136,0.0038425152,0.063956015,0.9213436],"study_design_scores_gemma":[0.000014493999,0.000047126912,0.0003862533,0.003313387,0.000054270786,0.0017985083,0.000042896532,0.00005458118,0.00010145115,0.0015814983,0.99259585,0.000009587406],"about_ca_topic_score_codex":0.00071038125,"about_ca_topic_score_gemma":0.0026134157,"teacher_disagreement_score":0.0046805562,"about_ca_system_score_codex":0.0006365199,"about_ca_system_score_gemma":0.00068748544,"threshold_uncertainty_score":0.015657961},"labels":[],"label_agreement":null},{"id":"W4225315024","doi":"10.2217/mmt-2021-0005","title":"Improved Overall Survival in Dual Compared to Single Immune Checkpoint Inhibitors in <i>BRAF</i> V600-Negative Advanced Melanoma","year":2022,"lang":"en","type":"article","venue":"Melanoma Management","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Melanoma; Medicine; Hazard ratio; Retrospective cohort study; Adverse effect; Internal medicine; Oncology; Immune system; Immune checkpoint; Gastroenterology; Immunotherapy; Cancer; Cancer research; Immunology; Confidence interval","score_opus":0.010721805563873874,"score_gpt":0.22081334006982017,"score_spread":0.2100915345059463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225315024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961378,0.0031260378,0.00009290169,0.000051578987,0.000019129326,0.000008515765,0.00011134762,0.0000031848444,0.00044945665],"genre_scores_gemma":[0.99919325,0.00042774368,0.00007458608,0.00003562468,0.000017074854,0.0000061674937,0.00010153908,9.0236426e-7,0.00014308139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983644,0.000043254222,0.000015056767,0.000050102568,0.00002521969,0.000029863191],"domain_scores_gemma":[0.9996692,0.00006667149,0.0001528303,0.000015184797,0.000021732638,0.00007445642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004355905,0.00015194419,0.00035447977,0.00022646868,0.00010093696,0.00039769354,0.00014065369,0.0001734874,0.000960578],"category_scores_gemma":[0.0006720437,0.0000669784,0.00040619925,0.00016359225,0.0001302993,0.0002632855,0.0002136458,0.00032537224,0.000097311095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048453115,0.001190457,0.7886461,0.00074883644,0.0012430967,0.00044186006,0.00010797528,0.0009615731,0.018459897,0.00015996885,0.00099511,0.13859196],"study_design_scores_gemma":[0.0013516417,0.023736252,0.9604721,0.00012302255,0.0013794932,0.0023448006,0.00019474493,0.0015064424,0.0050561717,0.00023260107,0.0035839663,0.00001872984],"about_ca_topic_score_codex":0.00020957734,"about_ca_topic_score_gemma":0.00051373267,"teacher_disagreement_score":0.000960578,"about_ca_system_score_codex":0.00023211604,"about_ca_system_score_gemma":0.00016907477,"threshold_uncertainty_score":0.0032134652},"labels":[],"label_agreement":null},{"id":"W4381663941","doi":"10.2217/mmt-2022-0002","title":"Primary Esophageal Melanoma: A Case Report","year":2022,"lang":"en","type":"article","venue":"Melanoma Management","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Melanoma; Dysphagia; Esophagectomy; Radiation therapy; Esophageal adenocarcinoma; Surgery; Adenocarcinoma; Mucosal melanoma; Esophageal cancer; General surgery; Radiology; Internal medicine; Cancer","score_opus":0.012011186301740381,"score_gpt":0.24048310101690354,"score_spread":0.22847191471516315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381663941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560391,0.018698383,0.005025049,0.0034062166,0.0011863143,0.00033831838,0.00042198066,0.0003925232,0.014492153],"genre_scores_gemma":[0.9873301,0.0049209124,0.0020756894,0.00089296344,0.0021357294,0.00007224514,0.00017328905,0.00003322565,0.0023658208],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99906343,0.00009096037,0.00013186905,0.000246518,0.0001482881,0.00031904085],"domain_scores_gemma":[0.9984773,0.00033612744,0.00036228908,0.00019458945,0.00010672734,0.0005229371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044996393,0.0027740863,0.0017198765,0.003334412,0.0036257848,0.0027151625,0.0014775546,0.0071445243,0.0035347727],"category_scores_gemma":[0.0025972566,0.0015216034,0.0014213672,0.0021052863,0.0017432078,0.0026004086,0.002766126,0.0035063014,0.0022161894],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012440701,0.000047541227,0.0026913104,0.000033314067,0.000008473479,0.9953792,0.00011820497,0.000035688394,0.00038994587,0.00008010438,0.0002704699,0.00093335385],"study_design_scores_gemma":[0.00000533054,0.000030909716,0.0015024836,0.000010585597,0.0000073921724,0.99774843,0.000079355115,0.0000738899,0.00009915276,0.000054676108,0.00038221746,0.0000055850314],"about_ca_topic_score_codex":0.0013945611,"about_ca_topic_score_gemma":0.002125231,"teacher_disagreement_score":0.0071445243,"about_ca_system_score_codex":0.0010612594,"about_ca_system_score_gemma":0.00071720534,"threshold_uncertainty_score":0.0118249655},"labels":[],"label_agreement":null},{"id":"W4407642584","doi":"10.1080/20450885.2025.2461963","title":"Efficacy and safety of adjuvant systemic therapies in trial non-eligible resected stages III and IV melanoma patients","year":2025,"lang":"en","type":"article","venue":"Melanoma Management","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; McMaster University; Saint John Regional Hospital","funders":"","keywords":"Medicine; Melanoma; Adjuvant; Oncology; Internal medicine; Clinical trial; Systemic therapy; Dermatology; Surgery; Cancer; Cancer research","score_opus":0.008029470310269411,"score_gpt":0.2509850295672508,"score_spread":0.24295555925698137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407642584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931293,0.0035795602,0.0002409738,0.00019407323,0.000022252802,0.00031493595,0.0004896707,0.000005612627,0.002023666],"genre_scores_gemma":[0.9981061,0.0005113973,0.000214408,0.0001196994,0.000029591083,0.0001969223,0.0005714249,0.0000025591796,0.0002476705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986312,0.0006870566,0.00019396591,0.00015925572,0.00021369771,0.00011484486],"domain_scores_gemma":[0.9957338,0.0013138163,0.0019267993,0.00025343182,0.00036893284,0.00040328864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036202883,0.00014069983,0.0005085216,0.00019995627,0.00030541123,0.0006254176,0.00019211335,0.0002779255,0.0012928605],"category_scores_gemma":[0.005867538,0.00007549474,0.00049347256,0.00036265005,0.0003584421,0.00031902592,0.00022267947,0.0004336321,0.00020567415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16906942,0.0025165451,0.6670284,0.0015915668,0.0011652794,0.0004494198,0.0004367473,0.00096420245,0.0055367663,0.00050339807,0.0024853486,0.1482529],"study_design_scores_gemma":[0.0135005275,0.09909722,0.86439896,0.00040033826,0.0012898772,0.0017632499,0.0004314075,0.0015286311,0.004480315,0.0007019086,0.012365262,0.000042301024],"about_ca_topic_score_codex":0.0010076013,"about_ca_topic_score_gemma":0.0024300967,"teacher_disagreement_score":0.0036202883,"about_ca_system_score_codex":0.00085128087,"about_ca_system_score_gemma":0.0015903353,"threshold_uncertainty_score":0.019146085},"labels":[],"label_agreement":null},{"id":"W4414912783","doi":"10.1080/20450885.2025.2545169","title":"Bridging gaps throughout a patient’s journey with melanoma: a systematic review","year":2025,"lang":"en","type":"review","venue":"Melanoma Management","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto; McMaster University","funders":"","keywords":"Bridging (networking); Health care; Best practice; Quality (philosophy); Patient experience; Quality management","score_opus":0.022029494479987886,"score_gpt":0.30104466472547536,"score_spread":0.2790151702454875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414912783","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010987484,0.9973014,0.00016708199,0.00034097373,0.00008593781,0.00042990674,0.00023758919,0.000007882199,0.0003305171],"genre_scores_gemma":[0.0126790935,0.98510265,0.0007144884,0.00047506712,0.00004707962,0.00069891376,0.00016813198,0.000004101279,0.00011048755],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9916666,0.0032995061,0.002801371,0.0005291271,0.0014311182,0.0002722378],"domain_scores_gemma":[0.9697138,0.022083629,0.004996154,0.00035425875,0.0024572392,0.000394877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008357572,0.0013722583,0.00603004,0.009577212,0.0010808088,0.0032073976,0.0018558617,0.0019921323,0.0043452526],"category_scores_gemma":[0.044617787,0.0011287115,0.006027988,0.011106296,0.00085151324,0.0034957111,0.0020073156,0.0015217925,0.00032872902],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085940526,0.000013880472,0.0005345518,0.96271425,0.004200966,0.00010354746,0.0004336779,0.0000419754,0.00007489678,0.00015887358,0.0011819911,0.030455396],"study_design_scores_gemma":[0.00007916227,0.000099752346,0.0018957092,0.954641,0.028318651,0.00029068996,0.00072754355,0.000039119273,0.00008137412,0.00019050809,0.013612846,0.000023660405],"about_ca_topic_score_codex":0.007536252,"about_ca_topic_score_gemma":0.028636103,"teacher_disagreement_score":0.009577212,"about_ca_system_score_codex":0.0040616416,"about_ca_system_score_gemma":0.01730697,"threshold_uncertainty_score":0.044199586},"labels":[],"label_agreement":null}]}